Automatically generated by Mendeley Desktop 1.15.2
Any changes to this file will be lost if it is regenerated by Mendeley.

BibTeX export options can be customized via Options -> BibTeX in Mendeley Desktop

@article{Purcell2014,
abstract = {Schizophrenia is a common disease with a complex aetiology, probably involving multiple and heterogeneous genetic factors. Here, by analysing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we demonstrate a polygenic burden primarily arising from rare (less than 1 in 10,000), disruptive mutations distributed across many genes. Particularly enriched gene sets include the voltage-gated calcium ion channel and the signalling complex formed by the activity-regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, sets previously implicated by genome-wide association and copy-number variation studies. Similar to reports in autism, targets of the fragile X mental retardation protein (FMRP, product of FMR1) are enriched for case mutations. No individual gene-based test achieves significance after correction for multiple testing and we do not detect any alleles of moderately low frequency (approximately 0.5 to 1 per cent) and moderately large effect. Taken together, these data suggest that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.},
annote = {Purcell, Shaun M
Moran, Jennifer L
Fromer, Menachem
Ruderfer, Douglas
Solovieff, Nadia
Roussos, Panos
O'Dushlaine, Colm
Chambert, Kimberly
Bergen, Sarah E
Kahler, Anna
Duncan, Laramie
Stahl, Eli
Genovese, Giulio
Fernandez, Esperanza
Collins, Mark O
Komiyama, Noboru H
Choudhary, Jyoti S
Magnusson, Patrik K E
Banks, Eric
Shakir, Khalid
Garimella, Kiran
Fennell, Tim
DePristo, Mark
Grant, Seth G N
Haggarty, Stephen J
Gabriel, Stacey
Scolnick, Edward M
Lander, Eric S
Hultman, Christina M
Sullivan, Patrick F
McCarroll, Steven A
Sklar, Pamela
R01 HG005827/HG/NHGRI NIH HHS/United States
R01 MH077139/MH/NIMH NIH HHS/United States
R01 MH091115/MH/NIMH NIH HHS/United States
R01 MH095034/MH/NIMH NIH HHS/United States
R01 MH095088/MH/NIMH NIH HHS/United States
R01 MH099126/MH/NIMH NIH HHS/United States
RC2MH089905/MH/NIMH NIH HHS/United States
T32 MH017119/MH/NIMH NIH HHS/United States
TT32MH017119/MH/NIMH NIH HHS/United States
U54 HG003067/HG/NHGRI NIH HHS/United States
U54HG003067/HG/NHGRI NIH HHS/United States
Medical Research Council/United Kingdom
Wellcome Trust/United Kingdom
Research Support, American Recovery and Reinvestment Act
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
Nature
Nature. 2014 Feb 13;506(7487):185-90. doi: 10.1038/nature12975. Epub 2014 Jan 22.},
author = {Purcell, S M and Moran, J L and Fromer, M and Ruderfer, D and Solovieff, N and Roussos, P and O'Dushlaine, C and Chambert, K and Bergen, S E and Kahler, A and Duncan, L and Stahl, E and Genovese, G and Fernandez, E and Collins, M O and Komiyama, N H and Choudhary, J S and Magnusson, P K and Banks, E and Shakir, K and Garimella, K and Fennell, T and DePristo, M and Grant, S G and Haggarty, S J and Gabriel, S and Scolnick, E M and Lander, E S and Hultman, C M and Sullivan, P F and McCarroll, S A and Sklar, P},
doi = {10.1038/nature12975 nature12975 [pii]},
edition = {2014/01/28},
file = {:C$\backslash$:/Users/shingwan/Dropbox/Papers/A polygenic burden of rare disruptive mutations in schizophrenia.pdf:pdf},
isbn = {1476-4687 (Electronic) 0028-0836 (Linking)},
journal = {Nature},
keywords = {Autistic Disorder/genetics,Calcium Channels/genetics,Cytoskeletal Proteins/genetics,DNA Copy Number Variations/genetics,Female,Fragile X Mental Retardation Protein/metabolism,Genome-Wide Association Study,Humans,Intellectual Disability/genetics,Intracellular Signaling Peptides and Proteins/gene,Male,Membrane Proteins/genetics,Multifactorial Inheritance/*genetics,Mutation/*genetics,N-Methyl-D-Aspartate/genetics,Nerve Tissue Proteins/genetics,Receptors,Schizophrenia/*genetics},
language = {eng},
number = {7487},
pages = {185--190},
pmid = {24463508},
title = {{A polygenic burden of rare disruptive mutations in schizophrenia}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24463508},
volume = {506},
year = {2014}
}
@article{Sanders2012,
abstract = {Multiple studies have confirmed the contribution of rare de novo copy number variations to the risk for autism spectrum disorders. But whereas de novo single nucleotide variants have been identified in affected individuals, their contribution to risk has yet to be clarified. Specifically, the frequency and distribution of these mutations have not been well characterized in matched unaffected controls, and such data are vital to the interpretation of de novo coding mutations observed in probands. Here we show, using whole-exome sequencing of 928 individuals, including 200 phenotypically discordant sibling pairs, that highly disruptive (nonsense and splice-site) de novo mutations in brain-expressed genes are associated with autism spectrum disorders and carry large effects. On the basis of mutation rates in unaffected individuals, we demonstrate that multiple independent de novo single nucleotide variants in the same gene among unrelated probands reliably identifies risk alleles, providing a clear path forward for gene discovery. Among a total of 279 identified de novo coding mutations, there is a single instance in probands, and none in siblings, in which two independent nonsense variants disrupt the same gene, SCN2A (sodium channel, voltage-gated, type II, alpha subunit), a result that is highly unlikely by chance.},
annote = {Sanders, Stephan J
Murtha, Michael T
Gupta, Abha R
Murdoch, John D
Raubeson, Melanie J
Willsey, A Jeremy
Ercan-Sencicek, A Gulhan
DiLullo, Nicholas M
Parikshak, Neelroop N
Stein, Jason L
Walker, Michael F
Ober, Gordon T
Teran, Nicole A
Song, Youeun
El-Fishawy, Paul
Murtha, Ryan C
Choi, Murim
Overton, John D
Bjornson, Robert D
Carriero, Nicholas J
Meyer, Kyle A
Bilguvar, Kaya
Mane, Shrikant M
Sestan, Nenad
Lifton, Richard P
Gunel, Murat
Roeder, Kathryn
Geschwind, Daniel H
Devlin, Bernie
State, Matthew W
K08 MH087639/MH/NIMH NIH HHS/United States
T32 GM008042/GM/NIGMS NIH HHS/United States
U01 MH081896/MH/NIMH NIH HHS/United States
Howard Hughes Medical Institute/United States
Research Support, Non-U.S. Gov't
England
Nature
Nature. 2012 Apr 4;485(7397):237-41. doi: 10.1038/nature10945.},
author = {Sanders, S J and Murtha, M T and Gupta, A R and Murdoch, J D and Raubeson, M J and Willsey, A J and Ercan-Sencicek, A G and DiLullo, N M and Parikshak, N N and Stein, J L and Walker, M F and Ober, G T and Teran, N A and Song, Y and El-Fishawy, P and Murtha, R C and Choi, M and Overton, J D and Bjornson, R D and Carriero, N J and Meyer, K A and Bilguvar, K and Mane, S M and Sestan, N and Lifton, R P and Gunel, M and Roeder, K and Geschwind, D H and Devlin, B and State, M W},
doi = {10.1038/nature10945nature10945 [pii]},
edition = {2012/04/13},
isbn = {1476-4687 (Electronic)0028-0836 (Linking)},
journal = {Nature},
keywords = {Alleles,Autistic Disorder/*genetics,Codon, Nonsense/genetics,Exome/*genetics,Exons/*genetics,Genetic Heterogeneity,Genetic Predisposition to Disease/*genetics,Humans,Mutation/*genetics,NAV1.2 Voltage-Gated Sodium Channel,Nerve Tissue Proteins/*genetics,RNA Splice Sites/genetics,Siblings,Sodium Channels/*genetics},
language = {eng},
number = {7397},
pages = {237--241},
pmid = {22495306},
title = {{De novo mutations revealed by whole-exome sequencing are strongly associated with autism}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/22495306},
volume = {485},
year = {2012}
}
@article{Anney2010a,
abstract = {Although autism spectrum disorders (ASDs) have a substantial genetic basis, most of the known genetic risk has been traced to rare variants, principally copy number variants (CNVs). To identify common risk variation, the Autism Genome Project (AGP) Consortium genotyped 1558 rigorously defined ASD families for 1 million single-nucleotide polymorphisms (SNPs) and analyzed these SNP genotypes for association with ASD. In one of four primary association analyses, the association signal for marker rs4141463, located within MACROD2, crossed the genome-wide association significance threshold of P < 5 x 10(-8). When a smaller replication sample was analyzed, the risk allele at rs4141463 was again over-transmitted; yet, consistent with the winner's curse, its effect size in the replication sample was much smaller; and, for the combined samples, the association signal barely fell below the P < 5 x 10(-8) threshold. Exploratory analyses of phenotypic subtypes yielded no significant associations after correction for multiple testing. They did, however, yield strong signals within several genes, KIAA0564, PLD5, POU6F2, ST8SIA2 and TAF1C.},
annote = {Anney, Richard
Klei, Lambertus
Pinto, Dalila
Regan, Regina
Conroy, Judith
Magalhaes, Tiago R
Correia, Catarina
Abrahams, Brett S
Sykes, Nuala
Pagnamenta, Alistair T
Almeida, Joana
Bacchelli, Elena
Bailey, Anthony J
Baird, Gillian
Battaglia, Agatino
Berney, Tom
Bolshakova, Nadia
Bolte, Sven
Bolton, Patrick F
Bourgeron, Thomas
Brennan, Sean
Brian, Jessica
Carson, Andrew R
Casallo, Guillermo
Casey, Jillian
Chu, Su H
Cochrane, Lynne
Corsello, Christina
Crawford, Emily L
Crossett, Andrew
Dawson, Geraldine
de Jonge, Maretha
Delorme, Richard
Drmic, Irene
Duketis, Eftichia
Duque, Frederico
Estes, Annette
Farrar, Penny
Fernandez, Bridget A
Folstein, Susan E
Fombonne, Eric
Freitag, Christine M
Gilbert, John
Gillberg, Christopher
Glessner, Joseph T
Goldberg, Jeremy
Green, Jonathan
Guter, Stephen J
Hakonarson, Hakon
Heron, Elizabeth A
Hill, Matthew
Holt, Richard
Howe, Jennifer L
Hughes, Gillian
Hus, Vanessa
Igliozzi, Roberta
Kim, Cecilia
Klauck, Sabine M
Kolevzon, Alexander
Korvatska, Olena
Kustanovich, Vlad
Lajonchere, Clara M
Lamb, Janine A
Laskawiec, Magdalena
Leboyer, Marion
Le Couteur, Ann
Leventhal, Bennett L
Lionel, Anath C
Liu, Xiao-Qing
Lord, Catherine
Lotspeich, Linda
Lund, Sabata C
Maestrini, Elena
Mahoney, William
Mantoulan, Carine
Marshall, Christian R
McConachie, Helen
McDougle, Christopher J
McGrath, Jane
McMahon, William M
Melhem, Nadine M
Merikangas, Alison
Migita, Ohsuke
Minshew, Nancy J
Mirza, Ghazala K
Munson, Jeff
Nelson, Stanley F
Noakes, Carolyn
Noor, Abdul
Nygren, Gudrun
Oliveira, Guiomar
Papanikolaou, Katerina
Parr, Jeremy R
Parrini, Barbara
Paton, Tara
Pickles, Andrew
Piven, Joseph
Posey, David J
Poustka, Annemarie
Poustka, Fritz
Prasad, Aparna
Ragoussis, Jiannis
Renshaw, Katy
Rickaby, Jessica
Roberts, Wendy
Roeder, Kathryn
Roge, Bernadette
Rutter, Michael L
Bierut, Laura J
Rice, John P
Salt, Jeff
Sansom, Katherine
Sato, Daisuke
Segurado, Ricardo
Senman, Lili
Shah, Naisha
Sheffield, Val C
Soorya, Latha
Sousa, Ines
Stoppioni, Vera
Strawbridge, Christina
Tancredi, Raffaella
Tansey, Katherine
Thiruvahindrapduram, Bhooma
Thompson, Ann P
Thomson, Susanne
Tryfon, Ana
Tsiantis, John
Van Engeland, Herman
Vincent, John B
Volkmar, Fred
Wallace, Simon
Wang, Kai
Wang, Zhouzhi
Wassink, Thomas H
Wing, Kirsty
Wittemeyer, Kerstin
Wood, Shawn
Yaspan, Brian L
Zurawiecki, Danielle
Zwaigenbaum, Lonnie
Betancur, Catalina
Buxbaum, Joseph D
Cantor, Rita M
Cook, Edwin H
Coon, Hilary
Cuccaro, Michael L
Gallagher, Louise
Geschwind, Daniel H
Gill, Michael
Haines, Jonathan L
Miller, Judith
Monaco, Anthony P
Nurnberger, John I Jr
Paterson, Andrew D
Pericak-Vance, Margaret A
Schellenberg, Gerard D
Scherer, Stephen W
Sutcliffe, James S
Szatmari, Peter
Vicente, Astrid M
Vieland, Veronica J
Wijsman, Ellen M
Devlin, Bernie
Ennis, Sean
Hallmayer, Joachim
075491/Z/04 UK/Wellcome Trust/United Kingdom
AS7462/Autism Speaks/United States
G0601030/Medical Research Council/United Kingdom
HD055751/HD/NICHD NIH HHS/United States
HD055782/HD/NICHD NIH HHS/United States
HD055784/HD/NICHD NIH HHS/United States
HD35465/HD/NICHD NIH HHS/United States
K01 MH077930/MH/NIMH NIH HHS/United States
MH057881/MH/NIMH NIH HHS/United States
MH061009/MH/NIMH NIH HHS/United States
MH06359/MH/NIMH NIH HHS/United States
MH066673/MH/NIMH NIH HHS/United States
MH077930/MH/NIMH NIH HHS/United States
MH080647/MH/NIMH NIH HHS/United States
MH081754/MH/NIMH NIH HHS/United States
MH52708/MH/NIMH NIH HHS/United States
MH55284/MH/NIMH NIH HHS/United States
MH66766/MH/NIMH NIH HHS/United States
NS026630/NS/NINDS NIH HHS/United States
NS042165/NS/NINDS NIH HHS/United States
NS049261/NS/NINDS NIH HHS/United States
P01 CA089392/CA/NCI NIH HHS/United States
P50 HD055751/HD/NICHD NIH HHS/United States
P50 HD055751-03/HD/NICHD NIH HHS/United States
P50 HD055782/HD/NICHD NIH HHS/United States
R01 DA013423/DA/NIDA NIH HHS/United States
R01 DA019963/DA/NIDA NIH HHS/United States
R01 DA019963-01A2/DA/NIDA NIH HHS/United States
R01 DA019963-02/DA/NIDA NIH HHS/United States
R01 DA019963-03/DA/NIDA NIH HHS/United States
R01 MH057881/MH/NIMH NIH HHS/United States
U01 HG004422/HG/NHGRI NIH HHS/United States
U01 HG004422-02/HG/NHGRI NIH HHS/United States
U01 HG004438/HG/NHGRI NIH HHS/United States
U01 HG004446/HG/NHGRI NIH HHS/United States
U10 AA008401/AA/NIAAA NIH HHS/United States
U19 HD035469/HD/NICHD NIH HHS/United States
U19 HD035469-06/HD/NICHD NIH HHS/United States
U19 HD035469-07/HD/NICHD NIH HHS/United States
U19 HD035469-08/HD/NICHD NIH HHS/United States
U19 HD035469-09/HD/NICHD NIH HHS/United States
U19 HD035469-10/HD/NICHD NIH HHS/United States
Canadian Institutes of Health Research/Canada
Howard Hughes Medical Institute/United States
Medical Research Council/United Kingdom
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
Human molecular genetics
Hum Mol Genet. 2010 Oct 15;19(20):4072-82. doi: 10.1093/hmg/ddq307. Epub 2010 Jul 27.},
author = {Anney, R and Klei, L and Pinto, D and Regan, R and Conroy, J and Magalhaes, T R and Correia, C and Abrahams, B S and Sykes, N and Pagnamenta, A T and Almeida, J and Bacchelli, E and Bailey, A J and Baird, G and Battaglia, A and Berney, T and Bolshakova, N and Bolte, S and Bolton, P F and Bourgeron, T and Brennan, S and Brian, J and Carson, A R and Casallo, G and Casey, J and Chu, S H and Cochrane, L and Corsello, C and Crawford, E L and Crossett, A and Dawson, G and de Jonge, M and Delorme, R and Drmic, I and Duketis, E and Duque, F and Estes, A and Farrar, P and Fernandez, B A and Folstein, S E and Fombonne, E and Freitag, C M and Gilbert, J and Gillberg, C and Glessner, J T and Goldberg, J and Green, J and Guter, S J and Hakonarson, H and Heron, E A and Hill, M and Holt, R and Howe, J L and Hughes, G and Hus, V and Igliozzi, R and Kim, C and Klauck, S M and Kolevzon, A and Korvatska, O and Kustanovich, V and Lajonchere, C M and Lamb, J A and Laskawiec, M and Leboyer, M and {Le Couteur}, A and Leventhal, B L and Lionel, A C and Liu, X Q and Lord, C and Lotspeich, L and Lund, S C and Maestrini, E and Mahoney, W and Mantoulan, C and Marshall, C R and McConachie, H and McDougle, C J and McGrath, J and McMahon, W M and Melhem, N M and Merikangas, A and Migita, O and Minshew, N J and Mirza, G K and Munson, J and Nelson, S F and Noakes, C and Noor, A and Nygren, G and Oliveira, G and Papanikolaou, K and Parr, J R and Parrini, B and Paton, T and Pickles, A and Piven, J and Posey, D J and Poustka, A and Poustka, F and Prasad, A and Ragoussis, J and Renshaw, K and Rickaby, J and Roberts, W and Roeder, K and Roge, B and Rutter, M L and Bierut, L J and Rice, J P and Salt, J and Sansom, K and Sato, D and Segurado, R and Senman, L and Shah, N and Sheffield, V C and Soorya, L and Sousa, I and Stoppioni, V and Strawbridge, C and Tancredi, R and Tansey, K and Thiruvahindrapduram, B and Thompson, A P and Thomson, S and Tryfon, A and Tsiantis, J and {Van Engeland}, H and Vincent, J B and Volkmar, F and Wallace, S and Wang, K and Wang, Z and Wassink, T H and Wing, K and Wittemeyer, K and Wood, S and Yaspan, B L and Zurawiecki, D and Zwaigenbaum, L and Betancur, C and Buxbaum, J D and Cantor, R M and Cook, E H and Coon, H and Cuccaro, M L and Gallagher, L and Geschwind, D H and Gill, M and Haines, J L and Miller, J and Monaco, A P and {Nurnberger  Jr.}, J I and Paterson, A D and Pericak-Vance, M A and Schellenberg, G D and Scherer, S W and Sutcliffe, J S and Szatmari, P and Vicente, A M and Vieland, V J and Wijsman, E M and Devlin, B and Ennis, S and Hallmayer, J},
doi = {10.1093/hmg/ddq307ddq307 [pii]},
edition = {2010/07/29},
isbn = {1460-2083 (Electronic)0964-6906 (Linking)},
journal = {Hum Mol Genet},
keywords = {*Genetic Predisposition to Disease,*Genome-Wide Association Study,*Polymorphism,Alleles,Autistic Disorder/*genetics,DNA Copy Number Variations,Databases,European Continental Ancestry Group/genetics,Genetic,Genetic Variation,Genome,Genotype,Human,Humans,Risk Factors,Single Nucleotide},
language = {eng},
number = {20},
pages = {4072--4082},
pmid = {20663923},
title = {{A genome-wide scan for common alleles affecting risk for autism}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20663923},
volume = {19},
year = {2010}
}
@article{Davis2007,
abstract = {Microarray technology has become a standard molecular biology tool. Experimental data have been generated on a huge number of organisms, tissue types, treatment conditions and disease states. The Gene Expression Omnibus (Barrett et al., 2005), developed by the National Center for Bioinformatics (NCBI) at the National Institutes of Health is a repository of nearly 140,000 gene expression experiments. The BioConductor project (Gentleman et al., 2004) is an open-source and open-development software project built in the R statistical programming environment (R Development core Team, 2005) for the analysis and comprehension of genomic data. The tools contained in the BioConductor project represent many state-of-the-art methods for the analysis of microarray and genomics data. We have developed a software tool that allows access to the wealth of information within GEO directly from BioConductor, eliminating many the formatting and parsing problems that have made such analyses labor-intensive in the past. The software, called GEOquery, effectively establishes a bridge between GEO and BioConductor. Easy access to GEO data from BioConductor will likely lead to new analyses of GEO data using novel and rigorous statistical and bioinformatic tools. Facilitating analyses and meta-analyses of microarray data will increase the efficiency with which biologically important conclusions can be drawn from published genomic data. Availability: GEOquery is available as part of the BioConductor project.},
annote = {Davis, Sean
Meltzer, Paul S
England
Bioinformatics (Oxford, England)
Bioinformatics. 2007 Jul 15;23(14):1846-7. Epub 2007 May 12.},
author = {Davis, S and Meltzer, P S},
doi = {btm254 [pii]10.1093/bioinformatics/btm254},
edition = {2007/05/15},
isbn = {1367-4811 (Electronic)1367-4803 (Linking)},
journal = {Bioinformatics},
keywords = {*Gene Expression Profiling,*Oligonucleotide Array Sequence Analysis,Algorithms,Cluster Analysis,Computational Biology/*methods,Computers,Data Interpretation, Statistical,Databases, Factual,Databases, Genetic,Information Storage and Retrieval,Programming Languages,Software},
language = {eng},
number = {14},
pages = {1846--1847},
pmid = {17496320},
title = {{GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/17496320},
volume = {23},
year = {2007}
}
@article{Berretta2012,
abstract = {Emerging evidence points to the involvement of the brain extracellular matrix (ECM) in the pathophysiology of schizophrenia (SZ). Abnormalities affecting several ECM components, including Reelin and chondroitin sulfate proteoglycans (CSPGs), have been described in subjects with this disease. Solid evidence supports the involvement of Reelin, an ECM glycoprotein involved in corticogenesis, synaptic functions and glutamate NMDA receptor regulation, expressed prevalently in distinct populations of GABAergic neurons, which secrete it into the ECM. Marked changes of Reelin expression in SZ have typically been reported in association with GABA-related abnormalities in subjects with SZ and bipolar disorder. Recent findings from our group point to substantial abnormalities affecting CSPGs, a main ECM component, in the amygdala and entorhinal cortex of subjects with schizophrenia, but not bipolar disorder. Striking increases of glial cells expressing CSPGs were accompanied by reductions of perineuronal nets, CSPG- and Reelin-enriched ECM aggregates enveloping distinct neuronal populations. CSPGs developmental and adult functions, including neuronal migration, axon guidance, synaptic and neurotransmission regulation are highly relevant to the pathophysiology of SZ. Together with reports of anomalies affecting several other ECM components, these findings point to the ECM as a key component of the pathology of SZ. We propose that ECM abnormalities may contribute to several aspects of the pathophysiology of this disease, including disrupted connectivity and neuronal migration, synaptic anomalies and altered GABAergic, glutamatergic and dopaminergic neurotransmission.},
annote = {Berretta, Sabina
R01 MH086522-01A2/MH/NIMH NIH HHS/United States
R21 MH083222-01/MH/NIMH NIH HHS/United States
Review
England
Neuropharmacology
Neuropharmacology. 2012 Mar;62(3):1584-97. doi: 10.1016/j.neuropharm.2011.08.010. Epub 2011 Aug 16.},
author = {Berretta, S},
doi = {10.1016/j.neuropharm.2011.08.010 S0028-3908(11)00343-1 [pii]},
edition = {2011/08/23},
file = {:C$\backslash$:/Users/shingwan/Dropbox/Papers/Extracellular matrix abnormalities in schizophrenia.pdf:pdf},
isbn = {1873-7064 (Electronic) 0028-3908 (Linking)},
journal = {Neuropharmacology},
keywords = {Animals,Extracellular Matrix Proteins/*metabolism,Extracellular Matrix/*metabolism/*pathology,Humans,Schizophrenia/*metabolism/*pathology,Signal Transduction},
language = {eng},
number = {3},
pages = {1584--1597},
pmid = {21856318},
title = {{Extracellular matrix abnormalities in schizophrenia}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/21856318},
volume = {62},
year = {2012}
}
@article{Eden2009,
abstract = {BACKGROUND: Since the inception of the GO annotation project, a variety of tools have been developed that support exploring and searching the GO database. In particular, a variety of tools that perform GO enrichment analysis are currently available. Most of these tools require as input a target set of genes and a background set and seek enrichment in the target set compared to the background set. A few tools also exist that support analyzing ranked lists. The latter typically rely on simulations or on union-bound correction for assigning statistical significance to the results. RESULTS: GOrilla is a web-based application that identifies enriched GO terms in ranked lists of genes, without requiring the user to provide explicit target and background sets. This is particularly useful in many typical cases where genomic data may be naturally represented as a ranked list of genes (e.g. by level of expression or of differential expression). GOrilla employs a flexible threshold statistical approach to discover GO terms that are significantly enriched at the top of a ranked gene list. Building on a complete theoretical characterization of the underlying distribution, called mHG, GOrilla computes an exact p-value for the observed enrichment, taking threshold multiple testing into account without the need for simulations. This enables rigorous statistical analysis of thousand of genes and thousands of GO terms in order of seconds. The output of the enrichment analysis is visualized as a hierarchical structure, providing a clear view of the relations between enriched GO terms. CONCLUSION: GOrilla is an efficient GO analysis tool with unique features that make a useful addition to the existing repertoire of GO enrichment tools. GOrilla's unique features and advantages over other threshold free enrichment tools include rigorous statistics, fast running time and an effective graphical representation. GOrilla is publicly available at: http://cbl-gorilla.cs.technion.ac.il},
annote = {Eden, Eran
Navon, Roy
Steinfeld, Israel
Lipson, Doron
Yakhini, Zohar
Research Support, Non-U.S. Gov't
England
BMC bioinformatics
BMC Bioinformatics. 2009 Feb 3;10:48. doi: 10.1186/1471-2105-10-48.},
author = {Eden, E and Navon, R and Steinfeld, I and Lipson, D and Yakhini, Z},
doi = {10.1186/1471-2105-10-481471-2105-10-48 [pii]},
edition = {2009/02/05},
isbn = {1471-2105 (Electronic)1471-2105 (Linking)},
journal = {BMC Bioinformatics},
keywords = {*Genes,*Software,Algorithms,Animals,Arabidopsis/genetics,Computational Biology/*methods,Data Interpretation, Statistical,Databases, Genetic,Gene Expression Profiling,Genomics/*methods,Humans,Information Storage and Retrieval/*methods,Internet,Models, Genetic,Models, Statistical,Terminology as Topic,User-Computer Interface,Yeasts/genetics},
language = {eng},
pages = {48},
pmid = {19192299},
title = {{GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19192299},
volume = {10},
year = {2009}
}
@article{Anders2010,
abstract = {High-throughput sequencing assays such as RNA-Seq, ChIP-Seq or barcode counting provide quantitative readouts in the form of count data. To infer differential signal in such data correctly and with good statistical power, estimation of data variability throughout the dynamic range and a suitable error model are required. We propose a method based on the negative binomial distribution, with variance and mean linked by local regression and present an implementation, DESeq, as an R/Bioconductor package.},
annote = {Anders, Simon
Huber, Wolfgang
Research Support, Non-U.S. Gov't
England
Genome biology
Genome Biol. 2010;11(10):R106. Epub 2010 Oct 27.},
author = {Anders, S and Huber, W},
doi = {gb-2010-11-10-r106 [pii]10.1186/gb-2010-11-10-r106},
edition = {2010/10/29},
isbn = {1465-6914 (Electronic)1465-6906 (Linking)},
journal = {Genome Biol},
keywords = {Animals,Binomial Distribution,Chromatin Immunoprecipitation/methods,Computational Biology/*methods,Drosophila/genetics,Gene Expression Profiling/*methods,High-Throughput Nucleotide Sequencing/methods,Linear Models,Models, Genetic,Saccharomyces cerevisiae/genetics,Sequence Analysis, RNA/*methods,Stem Cells,Tissue Culture Techniques},
language = {eng},
number = {10},
pages = {R106},
pmid = {20979621},
title = {{Differential expression analysis for sequence count data}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20979621},
volume = {11},
year = {2010}
}
@article{Bergeron2013,
abstract = {The impact of the group B streptococcus (GBS)-induced maternal inflammation on offspring's brain has not yet been investigated despite GBS being one of the most frequent bacteria colonizing or infecting pregnant women. According to our hypothesis GBS-induced maternal immune activation plays a role in offspring perinatal brain damage and subsequent neurodisabilities such as autism. Using a new preclinical rat model of maternal inflammation triggered by inactivated GBS, we demonstrated placental, neuropathological and behavioral impacts on offspring. GBS-exposed placentas presented cystic lesions and polymorphonuclear infiltration located within the decidual/maternal side of the placenta, contrasting with macrophagic infiltration and necrotic areas located in the labyrinth/fetal compartment of the placenta after lipopolysaccharide-induced maternal inflammation. Brain damage featured lateral ventricles widening, predominately in the male, reduction of periventricular external capsules thickness, oligodendrocyte loss, and disorganization of frontoparietal subcortical tissue with no glial proliferation. Autistic hallmarks were found in offspring exposed to GBS, namely deficits in motor behavior, social and communicative impairments, i.e. profound defects in the integration and response to both acoustic and chemical signals that are predominant modes of communication in rats. Surprisingly, only male offspring were affected by these combined autistic-like traits. Our results show for the first time that materno-fetal inflammatory response to GBS plays a role in the induction of placental and cerebral insults, remarkably recapitulating cardinal features of human autism such as gender dichotomy and neurobehavioral traits. Unlike other models of prenatal inflammatory brain damage (induced by viral/toll-like receptor 3 (TLR3) or Gram-negative/TLR4), maternal inflammation resulting from GBS/TLR2 interactions induced a distinctive pattern of chorioamnionitis and cerebral injuries. These results also provide important evidence that beyond genetic influences, modifiable environmental factors play a role in both the occurrence of autism and its gender imbalance.},
annote = {Bergeron, J D L
Deslauriers, J
Grignon, S
Fortier, L C
Lepage, M
Stroh, T
Poyart, C
Sebire, G
Canadian Institutes of Health Research/Canada
Research Support, Non-U.S. Gov't
Switzerland
Developmental neuroscience
Dev Neurosci. 2013;35(6):504-15. doi: 10.1159/000355656. Epub 2013 Nov 13.},
author = {Bergeron, J D and Deslauriers, J and Grignon, S and Fortier, L C and Lepage, M and Stroh, T and Poyart, C and Sebire, G},
doi = {10.1159/000355656000355656 [pii]},
edition = {2013/11/20},
isbn = {1421-9859 (Electronic)0378-5866 (Linking)},
journal = {Dev Neurosci},
keywords = {*Streptococcus agalactiae,Animals,Animals, Newborn,Autistic Disorder/*etiology,Behavior, Animal,Brain Injuries/microbiology/*pathology,Brain/drug effects/microbiology/*pathology,Female,Lipopolysaccharides/pharmacology,Male,Nerve Fibers, Myelinated/drug effects/pathology,Placenta/*metabolism,Pregnancy,Rats,Streptococcal Infections/*microbiology},
language = {eng},
number = {6},
pages = {504--515},
pmid = {24246964},
title = {{White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24246964},
volume = {35},
year = {2013}
}
@article{Dobin2013,
abstract = {MOTIVATION: Accurate alignment of high-throughput RNA-seq data is a challenging and yet unsolved problem because of the non-contiguous transcript structure, relatively short read lengths and constantly increasing throughput of the sequencing technologies. Currently available RNA-seq aligners suffer from high mapping error rates, low mapping speed, read length limitation and mapping biases. RESULTS: To align our large (>80 billon reads) ENCODE Transcriptome RNA-seq dataset, we developed the Spliced Transcripts Alignment to a Reference (STAR) software based on a previously undescribed RNA-seq alignment algorithm that uses sequential maximum mappable seed search in uncompressed suffix arrays followed by seed clustering and stitching procedure. STAR outperforms other aligners by a factor of >50 in mapping speed, aligning to the human genome 550 million 2 x 76 bp paired-end reads per hour on a modest 12-core server, while at the same time improving alignment sensitivity and precision. In addition to unbiased de novo detection of canonical junctions, STAR can discover non-canonical splices and chimeric (fusion) transcripts, and is also capable of mapping full-length RNA sequences. Using Roche 454 sequencing of reverse transcription polymerase chain reaction amplicons, we experimentally validated 1960 novel intergenic splice junctions with an 80-90{\%} success rate, corroborating the high precision of the STAR mapping strategy. AVAILABILITY AND IMPLEMENTATION: STAR is implemented as a standalone C++ code. STAR is free open source software distributed under GPLv3 license and can be downloaded from http://code.google.com/p/rna-star/.},
annote = {Dobin, Alexander
Davis, Carrie A
Schlesinger, Felix
Drenkow, Jorg
Zaleski, Chris
Jha, Sonali
Batut, Philippe
Chaisson, Mark
Gingeras, Thomas R
U54HG004557/HG/NHGRI NIH HHS/United States
Evaluation Studies
Research Support, N.I.H., Extramural
England
Bioinformatics (Oxford, England)
Bioinformatics. 2013 Jan 1;29(1):15-21. doi: 10.1093/bioinformatics/bts635. Epub 2012 Oct 25.},
author = {Dobin, A and Davis, C A and Schlesinger, F and Drenkow, J and Zaleski, C and Jha, S and Batut, P and Chaisson, M and Gingeras, T R},
doi = {10.1093/bioinformatics/bts635bts635 [pii]},
edition = {2012/10/30},
isbn = {1367-4811 (Electronic)1367-4803 (Linking)},
journal = {Bioinformatics},
keywords = {*Software,Algorithms,Cluster Analysis,Gene Expression Profiling,Genome, Human,Humans,RNA Splicing,Sequence Alignment/*methods,Sequence Analysis, RNA/methods},
language = {eng},
number = {1},
pages = {15--21},
pmid = {23104886},
title = {{STAR: ultrafast universal RNA-seq aligner}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/23104886},
volume = {29},
year = {2013}
}
@article{Mednick1988a,
abstract = {â€¢ In the context of a Finnish birth cohort, we tested the hypothesis that viral infection during the latter two thirds of fetal development would increase the risk of adult schizophrenic outcome. Psychiatric hospital diagnoses were recorded for all individuals in greater Helsinki who were fetuses during the 1957 type A2 influenza epidemic. Those exposed to the viral epidemic during their second trimester of fetal development were at elevated risk of being admitted to a psychiatric hospital with a diagnosis of schizophrenia. This was true for both males and females and independently in several psychiatric hospitals. The second-trimester effect was seen in the elevated proportion of schizophrenics among those admitted to a psychiatric hospital and also in higher rates of schizophrenia per 1000 live births in the city of Helsinki. The study has several limitations: (1) We have no direct evidence that the subjects actually suffered a viral Infection. (2) The psychiatric data were obtained only for subjects up to the age of 26 years, 56 days. (3) The findings are based on hospital diagnoses. (4) The determination of stage of gestation at time of exposure to the epidemic is based on date of birth. The viral Infection might have occurred outside the official epidemic window; the infant may have had a preterm or postterm delivery. These sources of error, however, should not serve to enhance the findings. The observed viral effect is interpreted as being one of many potential perturbations of gestation. We suggest that It is less the type than the timing of the disturbance during fetal neural development that is critical in determining risk for schizophrenia.},
annote = {From Duplicate 1 (Adult schizophrenia following prenatal exposure to an influenza epidemic - Mednick, S A; Machon, R A; Huttunen, M O; Bonett, D)

Mednick, S A
Machon, R A
Huttunen, M O
Bonett, D
1 K05 MH 00619-01/MH/NIMH NIH HHS/United States
5 R01 MH 37692-02/MH/NIMH NIH HHS/United States
Research Support, U.S. Gov't, P.H.S.
United states
Archives of general psychiatry
Arch Gen Psychiatry. 1988 Feb;45(2):189-92.

From Duplicate 2 (ADult schizophrenia following prenatal exposure to an influenza epidemic - SA, Mednick; RA, Machon; MO, Huttunen; Bonett, D)

10.1001/archpsyc.1988.01800260109013},
author = {Mednick, S A and Machon, R A and Huttunen, M O and Bonett, D},
edition = {1988/02/01},
isbn = {0003-990X (Print) 0003-990X (Linking)},
issn = {0003-990X},
journal = {Archives of General Psychiatry},
keywords = {*Disease Outbreaks,*Prenatal Exposure Delayed Effects,Adult,Female,Fetal Diseases/*complications,Finland,Hospitalization,Human/*complications,Humans,Influenza,Influenza A virus,Male,Pregnancy,Risk Factors,Schizophrenia/*epidemiology/etiology/genetics},
language = {eng},
month = {feb},
number = {2},
pages = {189--192},
pmid = {3337616},
title = {{Adult schizophrenia following prenatal exposure to an influenza epidemic}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/3337616},
volume = {45},
year = {1988}
}
@article{Neale2012,
abstract = {Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3{\%}) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case-control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.},
annote = {Neale, Benjamin M
Kou, Yan
Liu, Li
Ma'ayan, Avi
Samocha, Kaitlin E
Sabo, Aniko
Lin, Chiao-Feng
Stevens, Christine
Wang, Li-San
Makarov, Vladimir
Polak, Paz
Yoon, Seungtai
Maguire, Jared
Crawford, Emily L
Campbell, Nicholas G
Geller, Evan T
Valladares, Otto
Schafer, Chad
Liu, Han
Zhao, Tuo
Cai, Guiqing
Lihm, Jayon
Dannenfelser, Ruth
Jabado, Omar
Peralta, Zuleyma
Nagaswamy, Uma
Muzny, Donna
Reid, Jeffrey G
Newsham, Irene
Wu, Yuanqing
Lewis, Lora
Han, Yi
Voight, Benjamin F
Lim, Elaine
Rossin, Elizabeth
Kirby, Andrew
Flannick, Jason
Fromer, Menachem
Shakir, Khalid
Fennell, Tim
Garimella, Kiran
Banks, Eric
Poplin, Ryan
Gabriel, Stacey
DePristo, Mark
Wimbish, Jack R
Boone, Braden E
Levy, Shawn E
Betancur, Catalina
Sunyaev, Shamil
Boerwinkle, Eric
Buxbaum, Joseph D
Cook, Edwin H Jr
Devlin, Bernie
Gibbs, Richard A
Roeder, Kathryn
Schellenberg, Gerard D
Sutcliffe, James S
Daly, Mark J
KL2 RR024977/RR/NCRR NIH HHS/United States
KL2 TR000446/TR/NCATS NIH HHS/United States
P30 HD015052/HD/NICHD NIH HHS/United States
P50 GM071558/GM/NIGMS NIH HHS/United States
P50 HD055751/HD/NICHD NIH HHS/United States
R01 MH057881/MH/NIMH NIH HHS/United States
R01 MH061009/MH/NIMH NIH HHS/United States
R01 MH089004/MH/NIMH NIH HHS/United States
R01 MH089025/MH/NIMH NIH HHS/United States
R01 MH089175/MH/NIMH NIH HHS/United States
R01 MH089208/MH/NIMH NIH HHS/United States
R01 MH089482/MH/NIMH NIH HHS/United States
R01MH084676/MH/NIMH NIH HHS/United States
R01MH089175/MH/NIMH NIH HHS/United States
R01MH089208/MH/NIMH NIH HHS/United States
T32 GM007753/GM/NIGMS NIH HHS/United States
TL1 RR024978/RR/NCRR NIH HHS/United States
TL1 TR000447/TR/NCATS NIH HHS/United States
U01 HG006569/HG/NHGRI NIH HHS/United States
U54 HG003067/HG/NHGRI NIH HHS/United States
U54 HG003273/HG/NHGRI NIH HHS/United States
UL1 RR024975/RR/NCRR NIH HHS/United States
UL1 TR000445/TR/NCATS NIH HHS/United States
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
Nature
Nature. 2012 Apr 4;485(7397):242-5. doi: 10.1038/nature11011.},
author = {Neale, B M and Kou, Y and Liu, L and Ma'ayan, A and Samocha, K E and Sabo, A and Lin, C F and Stevens, C and Wang, L S and Makarov, V and Polak, P and Yoon, S and Maguire, J and Crawford, E L and Campbell, N G and Geller, E T and Valladares, O and Schafer, C and Liu, H and Zhao, T and Cai, G and Lihm, J and Dannenfelser, R and Jabado, O and Peralta, Z and Nagaswamy, U and Muzny, D and Reid, J G and Newsham, I and Wu, Y and Lewis, L and Han, Y and Voight, B F and Lim, E and Rossin, E and Kirby, A and Flannick, J and Fromer, M and Shakir, K and Fennell, T and Garimella, K and Banks, E and Poplin, R and Gabriel, S and DePristo, M and Wimbish, J R and Boone, B E and Levy, S E and Betancur, C and Sunyaev, S and Boerwinkle, E and Buxbaum, J D and {Cook  Jr.}, E H and Devlin, B and Gibbs, R A and Roeder, K and Schellenberg, G D and Sutcliffe, J S and Daly, M J},
doi = {10.1038/nature11011nature11011 [pii]},
edition = {2012/04/13},
isbn = {1476-4687 (Electronic)0028-0836 (Linking)},
journal = {Nature},
keywords = {Autistic Disorder/*genetics,Case-Control Studies,DNA-Binding Proteins/*genetics,Exome/genetics,Exons/*genetics,Family Health,Genetic Predisposition to Disease/*genetics,Humans,Models, Genetic,Multifactorial Inheritance/genetics,Mutation/*genetics,Phenotype,Poisson Distribution,Protein Interaction Maps,Transcription Factors/*genetics},
language = {eng},
number = {7397},
pages = {242--245},
pmid = {22495311},
title = {{Patterns and rates of exonic de novo mutations in autism spectrum disorders}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/22495311},
volume = {485},
year = {2012}
}
@article{Li2009c,
abstract = {OBJECTIVES: Maternal infection during pregnancy increases risk of severe neuropsychiatric disorders, including schizophrenia and autism, in the offspring. The most consistent brain structural abnormality in patients with schizophrenia is enlarged lateral ventricles. However, it is unknown whether the aetiology of ventriculomegaly in schizophrenia involves prenatal infectious processes. The present experiments tested the hypothesis that there is a causal relationship between prenatal immune challenge and emergence of ventricular abnormalities relevant to schizophrenia in adulthood. METHOD: We used an established mouse model of maternal immune activation (MIA) by the viral mimic PolyI:C administered in early (day 9) or late (day 17) gestation. Automated voxel-based morphometry mapped cerebrospinal fluid across the whole brain of adult offspring and the results were validated by manual region-of-interest tracing of the lateral ventricles. Parallel behavioral testing determined the existence of schizophrenia-related sensorimotor gating abnormalities. RESULTS: PolyI:C-induced immune activation, in early but not late gestation, caused marked enlargement of lateral ventricles in adulthood, without affecting total white and grey matter volumes. This early exposure disrupted sensorimotor gating, in the form of prepulse inhibition. Identical immune challenge in late gestation resulted in significant expansion of 4(th) ventricle volume but did not disrupt sensorimotor gating. CONCLUSIONS: Our results provide the first experimental evidence that prenatal immune activation is an environmental risk factor for adult ventricular enlargement relevant to schizophrenia. The data indicate immune-associated environmental insults targeting early foetal development may have more extensive neurodevelopmental impact than identical insults in late prenatal life.},
annote = {Li, Qi
Cheung, Charlton
Wei, Ran
Hui, Edward S
Feldon, Joram
Meyer, Urs
Chung, Sookja
Chua, Siew E
Sham, Pak C
Wu, Ed X
McAlonan, Grainne M
United States
PloS one
PLoS One. 2009 Jul 24;4(7):e6354.},
author = {Li, Q and Cheung, C and Wei, R and Hui, E S and Feldon, J and Meyer, U and Chung, S and Chua, S E and Sham, P C and Wu, E X and McAlonan, G M},
doi = {10.1371/journal.pone.0006354},
edition = {2009/07/25},
isbn = {1932-6203 (Electronic)1932-6203 (Linking)},
journal = {PLoS One},
keywords = {*Behavior, Animal,*Disease Models, Animal,*Maternal Exposure,Animals,Brain/*pathology,Female,Magnetic Resonance Imaging/*methods,Male,Mice,Mice, Inbred C57BL,Risk Factors,Schizophrenia/*immunology/pathology},
language = {eng},
number = {7},
pages = {e6354},
pmid = {19629183},
title = {{Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19629183},
volume = {4},
year = {2009}
}
@article{Meyer2007a,
abstract = {Environmental insults taking place in early brain development may have long-lasting consequences for adult brain functioning. There is a large body of epidemiological data linking maternal infections during pregnancy to a higher incidence of psychiatric disorders with a presumed neurodevelopmental origin in the offspring, including schizophrenia and autism. Although specific gestational windows may be associated with a differing vulnerability to infection-mediated disturbances in normal brain development, it still remains debatable whether and/or why certain gestation periods may confer maximal risk for neurodevelopmental disturbances following the prenatal exposure to infectious events. In this review, the authors integrate both epidemiological and experimental findings supporting the hypothesis that infection-associated immunological events in early fetal life may have a stronger neurodevelopmental impact compared to late pregnancy infections. This is because infections in early gestation may not only interfere with fundamental neurodevelopmental events such as cell proliferation and differentiation, but it may also predispose the developing nervous system to additional failures in subsequent cell migration, target selection, and synapse maturation, eventually leading to multiple brain and behavioral abnormalities in the adult offspring. The temporal dependency of the epidemiological link between maternal infections during pregnancy and a higher risk for brain disorders in the offspring may thus be explained by specific spatiotemporal events in the course of fetal brain development.},
annote = {Meyer, Urs
Yee, Benjamin K
Feldon, Joram
Research Support, Non-U.S. Gov't
Review
United States
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
Neuroscientist. 2007 Jun;13(3):241-56.},
author = {Meyer, U and Yee, B K and Feldon, J},
doi = {13/3/241 [pii] 10.1177/1073858406296401},
edition = {2007/05/24},
file = {:C$\backslash$:/Users/shingwan/Dropbox/Papers/The neurodevelopmental impact of prenatal infections at different times of pregnancy the earlier the worse.pdf:pdf},
isbn = {1073-8584 (Print) 1073-8584 (Linking)},
journal = {Neuroscientist},
keywords = {*Brain/embryology/growth {\&} development/physiopatho,Animal,Animals,Disease Models,Female,Fetal Development/*physiology,Humans,Infection/*complications,Mental Disorders/epidemiology/etiology,Pregnancy,Prenatal Exposure Delayed Effects/epidemiology/*et},
language = {eng},
number = {3},
pages = {241--256},
pmid = {17519367},
title = {{The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/17519367},
volume = {13},
year = {2007}
}
@article{Hartl2008,
abstract = {Mouse embryonic brain development involves sequential differentiation of multipotent progenitors into neurons and glia cells. Using microarrays and large 2-DE, we investigated the mouse brain transcriptome and proteome of embryonic days 9.5, 11.5, and 13.5. During this developmental period, neural progenitor cells shift from proliferation to neuronal differentiation. As expected, we detected numerous expression changes between all time points investigated, but interestingly, the rate of alteration remained in a similar range within 2 days of development. Furthermore, up- and down-regulation of gene products was balanced at each time point which was also seen at embryonic days 16-18. We hypothesize that during embryonic development, the rate of gene expression alteration is rather constant due to limited cellular resources such as energy, space, and free water. A similar complexity in terms of expressed genes and proteins suggests that changes in relative concentrations rather than an increase in the number of gene products dominate cellular differentiation. In general, expression of metabolism and cell cycle related gene products was down-regulated when precursor cells switched from proliferation to neuronal differentiation (days 9.5-11.5), whereas neuron specific gene products were up-regulated. A detailed functional analysis revealed their implication in differentiation related processes such as rearrangement of the actin cytoskeleton as well as Notch- and Wnt-signaling pathways.},
annote = {Hartl, Daniela
Irmler, Martin
Romer, Irmgard
Mader, Michael T
Mao, Lei
Zabel, Claus
de Angelis, Martin Hrabe
Beckers, Johannes
Klose, Joachim
Research Support, Non-U.S. Gov't
Germany
Proteomics
Proteomics. 2008 Mar;8(6):1257-65. doi: 10.1002/pmic.200700724.},
author = {Hartl, D and Irmler, M and Romer, I and Mader, M T and Mao, L and Zabel, C and de Angelis, M H and Beckers, J and Klose, J},
doi = {10.1002/pmic.200700724},
edition = {2008/02/20},
isbn = {1615-9861 (Electronic)1615-9853 (Linking)},
journal = {Proteomics},
keywords = {Animals,Brain/cytology/embryology/*metabolism,Electrophoresis, Gel, Two-Dimensional,Embryonic Development/*genetics,Gene Expression Profiling/*methods,Gene Expression Regulation, Developmental,Mice,Proteome/*analysis/genetics,Time Factors},
language = {eng},
number = {6},
pages = {1257--1265},
pmid = {18283662},
title = {{Transcriptome and proteome analysis of early embryonic mouse brain development}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/18283662},
volume = {8},
year = {2008}
}
@article{Robinson2010,
abstract = {SUMMARY: It is expected that emerging digital gene expression (DGE) technologies will overtake microarray technologies in the near future for many functional genomics applications. One of the fundamental data analysis tasks, especially for gene expression studies, involves determining whether there is evidence that counts for a transcript or exon are significantly different across experimental conditions. edgeR is a Bioconductor software package for examining differential expression of replicated count data. An overdispersed Poisson model is used to account for both biological and technical variability. Empirical Bayes methods are used to moderate the degree of overdispersion across transcripts, improving the reliability of inference. The methodology can be used even with the most minimal levels of replication, provided at least one phenotype or experimental condition is replicated. The software may have other applications beyond sequencing data, such as proteome peptide count data. AVAILABILITY: The package is freely available under the LGPL licence from the Bioconductor web site (http://bioconductor.org).},
annote = {Robinson, Mark D
McCarthy, Davis J
Smyth, Gordon K
Research Support, Non-U.S. Gov't
England
Bioinformatics (Oxford, England)
Bioinformatics. 2010 Jan 1;26(1):139-40. doi: 10.1093/bioinformatics/btp616. Epub 2009 Nov 11.},
author = {Robinson, M D and McCarthy, D J and Smyth, G K},
doi = {10.1093/bioinformatics/btp616btp616 [pii]},
edition = {2009/11/17},
isbn = {1367-4811 (Electronic)1367-4803 (Linking)},
journal = {Bioinformatics},
keywords = {*Algorithms,*Programming Languages,*Signal Processing, Computer-Assisted,*Software,Gene Expression Profiling/*methods,Oligonucleotide Array Sequence Analysis/*methods},
language = {eng},
number = {1},
pages = {139--140},
pmid = {19910308},
title = {{edgeR: a Bioconductor package for differential expression analysis of digital gene expression data}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19910308},
volume = {26},
year = {2010}
}
@article{Yuan2006,
abstract = {BACKGROUND: Even though real-time PCR has been broadly applied in biomedical sciences, data processing procedures for the analysis of quantitative real-time PCR are still lacking; specifically in the realm of appropriate statistical treatment. Confidence interval and statistical significance considerations are not explicit in many of the current data analysis approaches. Based on the standard curve method and other useful data analysis methods, we present and compare four statistical approaches and models for the analysis of real-time PCR data. RESULTS: In the first approach, a multiple regression analysis model was developed to derive DeltaDeltaCt from estimation of interaction of gene and treatment effects. In the second approach, an ANCOVA (analysis of covariance) model was proposed, and the DeltaDeltaCt can be derived from analysis of effects of variables. The other two models involve calculation DeltaCt followed by a two group t-test and non-parametric analogous Wilcoxon test. SAS programs were developed for all four models and data output for analysis of a sample set are presented. In addition, a data quality control model was developed and implemented using SAS. CONCLUSION: Practical statistical solutions with SAS programs were developed for real-time PCR data and a sample dataset was analyzed with the SAS programs. The analysis using the various models and programs yielded similar results. Data quality control and analysis procedures presented here provide statistical elements for the estimation of the relative expression of genes using real-time PCR.},
annote = {Yuan, Joshua S
Reed, Ann
Chen, Feng
Stewart, C Neal Jr
England
BMC bioinformatics
BMC Bioinformatics. 2006 Feb 22;7:85.},
author = {Yuan, J S and Reed, A and Chen, F and {Stewart  Jr.}, C N},
doi = {1471-2105-7-85 [pii]10.1186/1471-2105-7-85},
edition = {2006/03/01},
isbn = {1471-2105 (Electronic)1471-2105 (Linking)},
journal = {BMC Bioinformatics},
keywords = {*Data Interpretation, Statistical,Analysis of Variance,Animals,Base Pair Mismatch,Cloning, Molecular,Computational Biology/*methods,DNA Probes,DNA, Complementary,Gene Expression Profiling,Humans,Mice,Models, Biological,Models, Statistical,Oligonucleotide Array Sequence Analysis,Polymerase Chain Reaction,Programming Languages,Quality Control,RNA/chemistry,Regression Analysis,Reproducibility of Results,Reverse Transcriptase Polymerase Chain Reaction/*m,Sensitivity and Specificity,Software,Statistics as Topic},
language = {eng},
pages = {85},
pmid = {16504059},
title = {{Statistical analysis of real-time PCR data}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/16504059},
volume = {7},
year = {2006}
}
@article{Johnson2007,
abstract = {Non-biological experimental variation or "batch effects" are commonly observed across multiple batches of microarray experiments, often rendering the task of combining data from these batches difficult. The ability to combine microarray data sets is advantageous to researchers to increase statistical power to detect biological phenomena from studies where logistical considerations restrict sample size or in studies that require the sequential hybridization of arrays. In general, it is inappropriate to combine data sets without adjusting for batch effects. Methods have been proposed to filter batch effects from data, but these are often complicated and require large batch sizes ( > 25) to implement. Because the majority of microarray studies are conducted using much smaller sample sizes, existing methods are not sufficient. We propose parametric and non-parametric empirical Bayes frameworks for adjusting data for batch effects that is robust to outliers in small sample sizes and performs comparable to existing methods for large samples. We illustrate our methods using two example data sets and show that our methods are justifiable, easy to apply, and useful in practice. Software for our method is freely available at: http://biosun1.harvard.edu/complab/batch/.},
annote = {Johnson, W Evan
Li, Cheng
Rabinovic, Ariel
R01 HG02341/HG/NHGRI NIH HHS/United States
R01-CA82737/CA/NCI NIH HHS/United States
T32 CA009337/CA/NCI NIH HHS/United States
T32-CA09078/CA/NCI NIH HHS/United States
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
Biostatistics (Oxford, England)
Biostatistics. 2007 Jan;8(1):118-27. Epub 2006 Apr 21.},
author = {Johnson, W E and Li, C and Rabinovic, A},
doi = {kxj037 [pii]10.1093/biostatistics/kxj037},
edition = {2006/04/25},
isbn = {1465-4644 (Print)1465-4644 (Linking)},
journal = {Biostatistics},
keywords = {*Bayes Theorem,*Data Interpretation, Statistical,Gene Expression Profiling/methods,Humans,Oligonucleotide Array Sequence Analysis/*methods},
language = {eng},
number = {1},
pages = {118--127},
pmid = {16632515},
title = {{Adjusting batch effects in microarray expression data using empirical Bayes methods}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/16632515},
volume = {8},
year = {2007}
}
@article{Li2010a,
abstract = {Maternal infection during prenatal life is a risk factor for neurodevelopmental disorders, including schizophrenia and autism, in the offspring. We and others have reported white mater microstructure abnormalities in prefrontal-striato-temporal networks in these disorders. In addition we have shown that early rather than late maternal immune challenge in the mouse model precipitates ventricular volume change and impairs sensorimotor gating similar to that found in schizophrenia. However, it is not known whether the timing of maternal infection has a differential impact upon white matter microstructural indices. Therefore this study directly tested the effect of early or late gestation maternal immune activation on post-natal white matter microstructure in the mouse. The viral mimic PolyI:C was administered on day 9 or day 17 of gestation. In-vivo diffusion tensor imaging (DTI) was carried out when the offspring reached adulthood. We describe a novel application of voxel-based analysis to evaluate fractional anisotrophy (FA). In addition we conducted a preliminary immunohistochemical exploration of the oligodendrocyte marker, 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase), to determine whether differences in myelination might contribute to any changes in FA observed. Our results provide experimental evidence that prenatal exposure to inflammation elicits widespread differences in FA throughout fronto-striatal-limbic circuits compared to control saline exposure. Moreover, FA changes were more extensive in the group exposed earliest in gestation.},
annote = {Li, Qi
Cheung, Charlton
Wei, Ran
Cheung, Vinci
Hui, Edward S
You, Yuqi
Wong, Priscilla
Chua, Siew E
McAlonan, Grainne M
Wu, Ed X
United States
NeuroImage
Neuroimage. 2010 Aug 1;52(1):1-8. doi: 10.1016/j.neuroimage.2010.04.015. Epub 2010 Apr 23.},
author = {Li, Q and Cheung, C and Wei, R and Cheung, V and Hui, E S and You, Y and Wong, P and Chua, S E and McAlonan, G M and Wu, E X},
doi = {10.1016/j.neuroimage.2010.04.015S1053-8119(10)00409-X [pii]},
edition = {2010/04/20},
isbn = {1095-9572 (Electronic)1053-8119 (Linking)},
journal = {Neuroimage},
keywords = {*Prenatal Exposure Delayed Effects,2',3'-Cyclic-Nucleotide Phosphodiesterases/metabol,Animals,Anisotropy,Brain/enzymology/*pathology,Diffusion Tensor Imaging/*methods,Female,Image Processing, Computer-Assisted/*methods,Immunohistochemistry,Male,Mice,Mice, Inbred C57BL,Nerve Fibers, Myelinated/enzymology/pathology,Neural Pathways/enzymology/pathology,Oligodendroglia/enzymology/pathology,Pregnancy,Pregnancy Complications, Infectious/*immunology,Time Factors},
language = {eng},
number = {1},
pages = {1--8},
pmid = {20399275},
title = {{Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20399275},
volume = {52},
year = {2010}
}
@article{Ideker2002,
abstract = {MOTIVATION: In model organisms such as yeast, large databases of protein-protein and protein-DNA interactions have become an extremely important resource for the study of protein function, evolution, and gene regulatory dynamics. In this paper we demonstrate that by integrating these interactions with widely-available mRNA expression data, it is possible to generate concrete hypotheses for the underlying mechanisms governing the observed changes in gene expression. To perform this integration systematically and at large scale, we introduce an approach for screening a molecular interaction network to identify active subnetworks, i.e., connected regions of the network that show significant changes in expression over particular subsets of conditions. The method we present here combines a rigorous statistical measure for scoring subnetworks with a search algorithm for identifying subnetworks with high score. RESULTS: We evaluated our procedure on a small network of 332 genes and 362 interactions and a large network of 4160 genes containing all 7462 protein-protein and protein-DNA interactions in the yeast public databases. In the case of the small network, we identified five significant subnetworks that covered 41 out of 77 (53{\%}) of all significant changes in expression. Both network analyses returned several top-scoring subnetworks with good correspondence to known regulatory mechanisms in the literature. These results demonstrate how large-scale genomic approaches may be used to uncover signalling and regulatory pathways in a systematic, integrative fashion.},
annote = {Ideker, Trey
Ozier, Owen
Schwikowski, Benno
Siegel, Andrew F
Evaluation Studies
Research Support, Non-U.S. Gov't
England
Bioinformatics (Oxford, England)
Bioinformatics. 2002;18 Suppl 1:S233-40.},
author = {Ideker, T and Ozier, O and Schwikowski, B and Siegel, A F},
edition = {2002/08/10},
isbn = {1367-4803 (Print)1367-4803 (Linking)},
journal = {Bioinformatics},
keywords = {*Algorithms,*Models,Biological,Computer Simulation,Gene Expression Profiling/*methods,Gene Expression Regulation/*physiology,Proteome/*genetics/*metabolism,Signal Transduction/*physiology,Yeasts/physiology},
language = {eng},
pages = {S233--40},
pmid = {12169552},
title = {{Discovering regulatory and signalling circuits in molecular interaction networks}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/12169552},
volume = {18 Suppl 1},
year = {2002}
}
@article{Lein2007,
abstract = {Molecular approaches to understanding the functional circuitry of the nervous system promise new insights into the relationship between genes, brain and behaviour. The cellular diversity of the brain necessitates a cellular resolution approach towards understanding the functional genomics of the nervous system. We describe here an anatomically comprehensive digital atlas containing the expression patterns of approximately 20,000 genes in the adult mouse brain. Data were generated using automated high-throughput procedures for in situ hybridization and data acquisition, and are publicly accessible online. Newly developed image-based informatics tools allow global genome-scale structural analysis and cross-correlation, as well as identification of regionally enriched genes. Unbiased fine-resolution analysis has identified highly specific cellular markers as well as extensive evidence of cellular heterogeneity not evident in classical neuroanatomical atlases. This highly standardized atlas provides an open, primary data resource for a wide variety of further studies concerning brain organization and function.},
annote = {Lein, Ed S
Hawrylycz, Michael J
Ao, Nancy
Ayres, Mikael
Bensinger, Amy
Bernard, Amy
Boe, Andrew F
Boguski, Mark S
Brockway, Kevin S
Byrnes, Emi J
Chen, Lin
Chen, Li
Chen, Tsuey-Ming
Chin, Mei Chi
Chong, Jimmy
Crook, Brian E
Czaplinska, Aneta
Dang, Chinh N
Datta, Suvro
Dee, Nick R
Desaki, Aimee L
Desta, Tsega
Diep, Ellen
Dolbeare, Tim A
Donelan, Matthew J
Dong, Hong-Wei
Dougherty, Jennifer G
Duncan, Ben J
Ebbert, Amanda J
Eichele, Gregor
Estin, Lili K
Faber, Casey
Facer, Benjamin A
Fields, Rick
Fischer, Shanna R
Fliss, Tim P
Frensley, Cliff
Gates, Sabrina N
Glattfelder, Katie J
Halverson, Kevin R
Hart, Matthew R
Hohmann, John G
Howell, Maureen P
Jeung, Darren P
Johnson, Rebecca A
Karr, Patrick T
Kawal, Reena
Kidney, Jolene M
Knapik, Rachel H
Kuan, Chihchau L
Lake, James H
Laramee, Annabel R
Larsen, Kirk D
Lau, Christopher
Lemon, Tracy A
Liang, Agnes J
Liu, Ying
Luong, Lon T
Michaels, Jesse
Morgan, Judith J
Morgan, Rebecca J
Mortrud, Marty T
Mosqueda, Nerick F
Ng, Lydia L
Ng, Randy
Orta, Geralyn J
Overly, Caroline C
Pak, Tu H
Parry, Sheana E
Pathak, Sayan D
Pearson, Owen C
Puchalski, Ralph B
Riley, Zackery L
Rockett, Hannah R
Rowland, Stephen A
Royall, Joshua J
Ruiz, Marcos J
Sarno, Nadia R
Schaffnit, Katherine
Shapovalova, Nadiya V
Sivisay, Taz
Slaughterbeck, Clifford R
Smith, Simon C
Smith, Kimberly A
Smith, Bryan I
Sodt, Andy J
Stewart, Nick N
Stumpf, Kenda-Ruth
Sunkin, Susan M
Sutram, Madhavi
Tam, Angelene
Teemer, Carey D
Thaller, Christina
Thompson, Carol L
Varnam, Lee R
Visel, Axel
Whitlock, Ray M
Wohnoutka, Paul E
Wolkey, Crissa K
Wong, Victoria Y
Wood, Matthew
Yaylaoglu, Murat B
Young, Rob C
Youngstrom, Brian L
Yuan, Xu Feng
Zhang, Bin
Zwingman, Theresa A
Jones, Allan R
Research Support, Non-U.S. Gov't
England
Nature
Nature. 2007 Jan 11;445(7124):168-76. Epub 2006 Dec 6.},
author = {Lein, E S and Hawrylycz, M J and Ao, N and Ayres, M and Bensinger, A and Bernard, A and Boe, A F and Boguski, M S and Brockway, K S and Byrnes, E J and Chen, L and Chen, T M and Chin, M C and Chong, J and Crook, B E and Czaplinska, A and Dang, C N and Datta, S and Dee, N R and Desaki, A L and Desta, T and Diep, E and Dolbeare, T A and Donelan, M J and Dong, H W and Dougherty, J G and Duncan, B J and Ebbert, A J and Eichele, G and Estin, L K and Faber, C and Facer, B A and Fields, R and Fischer, S R and Fliss, T P and Frensley, C and Gates, S N and Glattfelder, K J and Halverson, K R and Hart, M R and Hohmann, J G and Howell, M P and Jeung, D P and Johnson, R A and Karr, P T and Kawal, R and Kidney, J M and Knapik, R H and Kuan, C L and Lake, J H and Laramee, A R and Larsen, K D and Lau, C and Lemon, T A and Liang, A J and Liu, Y and Luong, L T and Michaels, J and Morgan, J J and Morgan, R J and Mortrud, M T and Mosqueda, N F and Ng, L L and Ng, R and Orta, G J and Overly, C C and Pak, T H and Parry, S E and Pathak, S D and Pearson, O C and Puchalski, R B and Riley, Z L and Rockett, H R and Rowland, S A and Royall, J J and Ruiz, M J and Sarno, N R and Schaffnit, K and Shapovalova, N V and Sivisay, T and Slaughterbeck, C R and Smith, S C and Smith, K A and Smith, B I and Sodt, A J and Stewart, N N and Stumpf, K R and Sunkin, S M and Sutram, M and Tam, A and Teemer, C D and Thaller, C and Thompson, C L and Varnam, L R and Visel, A and Whitlock, R M and Wohnoutka, P E and Wolkey, C K and Wong, V Y and Wood, M and Yaylaoglu, M B and Young, R C and Youngstrom, B L and Yuan, X F and Zhang, B and Zwingman, T A and Jones, A R},
doi = {nature05453 [pii]10.1038/nature05453},
edition = {2006/12/08},
isbn = {1476-4687 (Electronic)0028-0836 (Linking)},
journal = {Nature},
keywords = {*Gene Expression Profiling,*Gene Expression Regulation,Animals,Brain/anatomy {\&} histology/cytology/*metabolism,Computational Biology,Genome/*genetics,Genomics,Hippocampus/anatomy {\&} histology/metabolism,Male,Mice,Mice, Inbred C57BL,Organ Specificity,RNA, Messenger/genetics/metabolism},
language = {eng},
number = {7124},
pages = {168--176},
pmid = {17151600},
title = {{Genome-wide atlas of gene expression in the adult mouse brain}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/17151600},
volume = {445},
year = {2007}
}
@article{Wassef2003,
abstract = {BACKGROUND: A converging body of evidence implicates the gamma-aminobutyric acid (GABA) neurotransmitter system in the pathogenesis of schizophrenia. METHODS: The authors review neuroscience literature and clinical studies investigating the role of the GABA system in the pathophysiology of schizophrenia. First, a background on the GABA system is provided, including GABA pharmacology and neuroanatomy of GABAergic neurons. Results from basic science schizophrenia animal models and human studies are reviewed. The role of GABA in cognitive dysfunction in schizophrenia is then presented, followed by a discussion of GABAergic compounds used in monotherapy or adjunctively in clinical schizophrenia studies. RESULTS: In basic studies, reductions in GABAergic neuronal density and abnormalities in receptors and reuptake sites have been identified in several cortical and subcortical GABA systems. A model has been developed suggesting GABA's role (including GABA-dopamine interactions) in schizophrenia. In several clinical studies, the use of adjunctive GABA agonists was associated with greater improvement in core schizophrenia symptoms. CONCLUSIONS: Alterations in the GABA neurotransmitter system are found in clinical and basic neuroscience schizophrenia studies as well as animal models and may be involved in the pathophysiology of schizophrenia. The interaction of GABA with other well-characterized neurotransmitter abnormalities remains to be understood. Future studies should elucidate the potential therapeutic role for GABA ligands in schizophrenia treatment.},
annote = {Wassef, Adel
Baker, Jeffrey
Kochan, Lisa D
Research Support, Non-U.S. Gov't
Review
United States
Journal of clinical psychopharmacology
J Clin Psychopharmacol. 2003 Dec;23(6):601-40.},
author = {Wassef, A and Baker, J and Kochan, L D},
doi = {10.1097/01.jcp.0000095349.32154.a500004714-200312000-00011 [pii]},
edition = {2003/11/19},
isbn = {0271-0749 (Print)0271-0749 (Linking)},
journal = {J Clin Psychopharmacol},
keywords = {Animals,Clinical Trials as Topic,GABA Agents/pharmacology/therapeutic use,Humans,Receptors, GABA-A/*physiology,Schizophrenia/drug therapy/etiology/*physiopatholo,gamma-Aminobutyric Acid/*physiology},
language = {eng},
number = {6},
pages = {601--640},
pmid = {14624191},
title = {{GABA and schizophrenia: a review of basic science and clinical studies}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/14624191},
volume = {23},
year = {2003}
}
@article{Miller2011,
abstract = {BACKGROUND: Genomic and other high dimensional analyses often require one to summarize multiple related variables by a single representative. This task is also variously referred to as collapsing, combining, reducing, or aggregating variables. Examples include summarizing several probe measurements corresponding to a single gene, representing the expression profiles of a co-expression module by a single expression profile, and aggregating cell-type marker information to de-convolute expression data. Several standard statistical summary techniques can be used, but network methods also provide useful alternative methods to find representatives. Currently few collapsing functions are developed and widely applied. RESULTS: We introduce the R function collapseRows that implements several collapsing methods and evaluate its performance in three applications. First, we study a crucial step of the meta-analysis of microarray data: the merging of independent gene expression data sets, which may have been measured on different platforms. Toward this end, we collapse multiple microarray probes for a single gene and then merge the data by gene identifier. We find that choosing the probe with the highest average expression leads to best between-study consistency. Second, we study methods for summarizing the gene expression profiles of a co-expression module. Several gene co-expression network analysis applications show that the optimal collapsing strategy depends on the analysis goal. Third, we study aggregating the information of cell type marker genes when the aim is to predict the abundance of cell types in a tissue sample based on gene expression data ("expression deconvolution"). We apply different collapsing methods to predict cell type abundances in peripheral human blood and in mixtures of blood cell lines. Interestingly, the most accurate prediction method involves choosing the most highly connected "hub" marker gene. Finally, to facilitate biological interpretation of collapsed gene lists, we introduce the function userListEnrichment, which assesses the enrichment of gene lists for known brain and blood cell type markers, and for other published biological pathways. CONCLUSIONS: The R function collapseRows implements several standard and network-based collapsing methods. In various genomic applications we provide evidence that both types of methods are robust and biologically relevant tools.},
annote = {Miller, Jeremy A
Cai, Chaochao
Langfelder, Peter
Geschwind, Daniel H
Kurian, Sunil M
Salomon, Daniel R
Horvath, Steve
F31 AG031649/AG/NIA NIH HHS/United States
P01 HL030568/HL/NHLBI NIH HHS/United States
P50CA092131/CA/NCI NIH HHS/United States
R01 AG26938-05/AG/NIA NIH HHS/United States
U19 AI063603-07/AI/NIAID NIH HHS/United States
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
BMC bioinformatics
BMC Bioinformatics. 2011 Aug 4;12:322. doi: 10.1186/1471-2105-12-322.},
author = {Miller, J A and Cai, C and Langfelder, P and Geschwind, D H and Kurian, S M and Salomon, D R and Horvath, S},
doi = {10.1186/1471-2105-12-3221471-2105-12-322 [pii]},
edition = {2011/08/06},
isbn = {1471-2105 (Electronic)1471-2105 (Linking)},
journal = {BMC Bioinformatics},
keywords = {*Models, Statistical,Animals,Blood/metabolism,Brain/metabolism,Gene Expression Profiling/*methods,Gene Expression Regulation,Humans,Meta-Analysis as Topic,Mice,Oligonucleotide Array Sequence Analysis/*methods},
language = {eng},
pages = {322},
pmid = {21816037},
title = {{Strategies for aggregating gene expression data: the collapseRows R function}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/21816037},
volume = {12},
year = {2011}
}
@article{ORoak2012,
abstract = {It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70{\%} of cases, the underlying genetic cause is unknown. Under the hypothesis that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or related phenotypes--so-called sporadic or simplex families--we sequenced all coding regions of the genome (the exome) for parent-child trios exhibiting sporadic ASD, including 189 new trios and 20 that were previously reported. Additionally, we also sequenced the exomes of 50 unaffected siblings corresponding to these new (n = 31) and previously reported trios (n = 19), for a total of 677 individual exomes from 209 families. Here we show that de novo point mutations are overwhelmingly paternal in origin (4:1 bias) and positively correlated with paternal age, consistent with the modest increased risk for children of older fathers to develop ASD. Moreover, 39{\%} (49 of 126) of the most severe or disruptive de novo mutations map to a highly interconnected beta-catenin/chromatin remodelling protein network ranked significantly for autism candidate genes. In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1. Mutation screening of six candidate genes in 1,703 ASD probands identified additional de novo, protein-altering mutations in GRIN2B, LAMC3 and SCN1A. Combined with copy number variant (CNV) data, these results indicate extreme locus heterogeneity but also provide a target for future discovery, diagnostics and therapeutics.},
annote = {O'Roak, Brian J
Vives, Laura
Girirajan, Santhosh
Karakoc, Emre
Krumm, Niklas
Coe, Bradley P
Levy, Roie
Ko, Arthur
Lee, Choli
Smith, Joshua D
Turner, Emily H
Stanaway, Ian B
Vernot, Benjamin
Malig, Maika
Baker, Carl
Reilly, Beau
Akey, Joshua M
Borenstein, Elhanan
Rieder, Mark J
Nickerson, Deborah A
Bernier, Raphael
Shendure, Jay
Eichler, Evan E
HD065285/HD/NICHD NIH HHS/United States
HHSN273200800010C/PHS HHS/United States
HL 094976/HL/NHLBI NIH HHS/United States
HL 1029230/HL/NHLBI NIH HHS/United States
HL 102924/HL/NHLBI NIH HHS/United States
HL102926/HL/NHLBI NIH HHS/United States
R01 HD065285-02/HD/NICHD NIH HHS/United States
Howard Hughes Medical Institute/United States
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
Nature
Nature. 2012 Apr 4;485(7397):246-50. doi: 10.1038/nature10989.},
author = {O'Roak, B J and Vives, L and Girirajan, S and Karakoc, E and Krumm, N and Coe, B P and Levy, R and Ko, A and Lee, C and Smith, J D and Turner, E H and Stanaway, I B and Vernot, B and Malig, M and Baker, C and Reilly, B and Akey, J M and Borenstein, E and Rieder, M J and Nickerson, D A and Bernier, R and Shendure, J and Eichler, E E},
doi = {10.1038/nature10989nature10989 [pii]},
edition = {2012/04/13},
isbn = {1476-4687 (Electronic)0028-0836 (Linking)},
journal = {Nature},
keywords = {Autistic Disorder/*genetics,DNA-Binding Proteins/genetics,Exome/*genetics,Exons/*genetics,GPI-Linked Proteins/genetics,Genetic Predisposition to Disease/genetics,Humans,Laminin/genetics,NAV1.1 Voltage-Gated Sodium Channel,Nerve Tissue Proteins/genetics,Parents,Point Mutation/*genetics,Protein Interaction Maps/*genetics,Receptors, N-Methyl-D-Aspartate/genetics,Reproducibility of Results,Siblings,Signal Transduction,Sodium Channels/genetics,Stochastic Processes,Transcription Factors/genetics,Tumor Suppressor Protein p53/metabolism,beta Catenin/metabolism},
language = {eng},
number = {7397},
pages = {246--250},
pmid = {22495309},
title = {{Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/22495309},
volume = {485},
year = {2012}
}
@article{Fromer2014,
abstract = {Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one or a few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-d-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.},
annote = {Fromer, Menachem
Pocklington, Andrew J
Kavanagh, David H
Williams, Hywel J
Dwyer, Sarah
Gormley, Padhraig
Georgieva, Lyudmila
Rees, Elliott
Palta, Priit
Ruderfer, Douglas M
Carrera, Noa
Humphreys, Isla
Johnson, Jessica S
Roussos, Panos
Barker, Douglas D
Banks, Eric
Milanova, Vihra
Grant, Seth G
Hannon, Eilis
Rose, Samuel A
Chambert, Kimberly
Mahajan, Milind
Scolnick, Edward M
Moran, Jennifer L
Kirov, George
Palotie, Aarno
McCarroll, Steven A
Holmans, Peter
Sklar, Pamela
Owen, Michael J
Purcell, Shaun M
O'Donovan, Michael C
2 P50MH066392-05A1/MH/NIMH NIH HHS/United States
G0800509/Medical Research Council/United Kingdom
G0801418/Medical Research Council/United Kingdom
R01HG005827/HG/NHGRI NIH HHS/United States
R01MH071681/MH/NIMH NIH HHS/United States
R01MH099126/MH/NIMH NIH HHS/United States
WT089062/Wellcome Trust/United Kingdom
WT098051/Wellcome Trust/United Kingdom
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
England
Nature
Nature. 2014 Feb 13;506(7487):179-84. doi: 10.1038/nature12929. Epub 2014 Jan 22.},
author = {Fromer, M and Pocklington, A J and Kavanagh, D H and Williams, H J and Dwyer, S and Gormley, P and Georgieva, L and Rees, E and Palta, P and Ruderfer, D M and Carrera, N and Humphreys, I and Johnson, J S and Roussos, P and Barker, D D and Banks, E and Milanova, V and Grant, S G and Hannon, E and Rose, S A and Chambert, K and Mahajan, M and Scolnick, E M and Moran, J L and Kirov, G and Palotie, A and McCarroll, S A and Holmans, P and Sklar, P and Owen, M J and Purcell, S M and O'Donovan, M C},
doi = {10.1038/nature12929nature12929 [pii]},
edition = {2014/01/28},
isbn = {1476-4687 (Electronic)0028-0836 (Linking)},
journal = {Nature},
keywords = {*Models, Neurological,Child Development Disorders, Pervasive/genetics,Cytoskeletal Proteins/metabolism,Exome/genetics,Fragile X Mental Retardation Protein/metabolism,Humans,Intellectual Disability/genetics,Mutation Rate,Mutation/*genetics,Nerve Net/*metabolism/physiopathology,Nerve Tissue Proteins/metabolism,Neural Pathways/*metabolism/physiopathology,Phenotype,RNA, Messenger/genetics/metabolism,Receptors, N-Methyl-D-Aspartate/metabolism,Schizophrenia/*genetics/metabolism/*physiopatholog,Substrate Specificity,Synapses/*metabolism},
language = {eng},
number = {7487},
pages = {179--184},
pmid = {24463507},
title = {{De novo mutations in schizophrenia implicate synaptic networks}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24463507},
volume = {506},
year = {2014}
}
